Programmed Intermittent Epidural Bolus Versus Continuous Epidural Infusion for Third Trimester Medical Termination of Pregnancy Analgesia : a Randomized Study. (PCEA-IMG)
Launched by UNIVERSITY HOSPITAL, LIMOGES · Sep 29, 2015
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
Abstract : The recent technical advances in antenatal diagnosis have led to an increase number of legally induced abortion at the third trimester of pregnancy. Psychological pain is frequently associated to physical pain in these kinds of interventions. So anaesthetists are more and more involved in voluntary termination of pregnancy analgesia.
In France, Patient Controlled Epidural Analgesia (PCEA) with CEI mode is usually used for voluntary termination of pregnancy analgesia. But recent studies have shown that PIEB mode as compared to CEI mode increases maternal satisfaction during labou...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • age ≥ 18 years
- • ASA 1 or 2 (healthy women)
- • pregnancy at third trimester
- • willingness of voluntary interrupt the pregnancy
- • women affiliated to french health social system
- • written informed consent from every patient
- Exclusion Criteria:
- • contraindications to epidural analgesia
- • opioids consumption within the last 24 hours
- • patient's unwillingness
- • inability to comprehend or comply with the procedure
About University Hospital, Limoges
The University Hospital of Limoges is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates patient care with cutting-edge research initiatives, fostering collaboration among healthcare professionals, researchers, and academic partners. With a commitment to improving patient outcomes and contributing to medical knowledge, the University Hospital of Limoges plays a pivotal role in translating scientific discoveries into effective therapeutic strategies. Its state-of-the-art facilities and expertise in various medical fields ensure rigorous trial management and adherence to ethical standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Limoges, , France
Patients applied
Trial Officials
Patrick SENGES, MD
Principal Investigator
University Hospital, Limoges
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials